Diabetes drugs linked to cancer in preliminary study

09/22/2011 | HealthDay News

An examination of the FDA's database on adverse events found a greater than twofold increase in pancreatic cancer among type 2 diabetes patients using Byetta or Januvia. Byetta was also associated with an increase in reported cases of thyroid cancer. The findings aren't conclusive but do indicate a need for further investigation, the researchers reported in Gastroenterology.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT